S181 ostopenia in the mechanism of rapidly destructive hip osteoarthritis. We confirm the presence of subchondral insufficiency fracture in hip with RDA.
. Perforation to endplate area ratio and years after menopause. Fig. 2 tions, or Schmorl's nodes. These could possibly act as openings through which pressure-induced escape of the disk nucleus could occur, and suggests that disk herniation into the weakened vertebral body through the perforated endplates can cause OAinducing instability in the same manner as the lateral slippage of the disk. We further calculated the ratio of the perforations to the area of the endplates and found that the there was a significant correlation between the perforation/endplate area ratio and the number of years after menopause. Conclusions: Close examination of 3-D renderings of the osteoporotic vertebrae revealed that the vertebral endplates of post-menopausal women are often compromised with indentations and perforations whose ratio to the area of the endplates increase with years after menopause. In at least some of the cases, the apparent narrowing of the intervertebral space resulting in the contact of the vertebral rims and the subsequent OA changes, in what has conventionally been known as fish-shaped vertebral fractures, may in fact be secondary to the herniation of the disk nucleus into the weakened vertebral body of the osteoporotic spine. Purpose: Previous investigations have presented conflicting evidence concerning a potential association between gynaecologic and reproductive factors and osteoarthritis (OA). Support for a hormonal association with OA comes from retrospective studies suggesting that women who have had a surgically induced menopause have a 2-fold increase for the risk of OA when compared with controls. Conflicting reports from previous studies have suggested both positive and negative effects of hormone replacement therapy (HRT) on the incidence of OA following hysterectomy. The aim of this investigation was to determine whether self-reported OA is associated with total hysterectomy and/or HRT use in a large cohort of women. Methods: Between 1990 Between -1994 women, aged between 49-54 years (mean 48.5±2.3)) were recruited randomly from a community health index for the Aberdeen Prospective Osteoporosis Screening Study (APOSS). Each was weighed, their height measured and asked questions relating to bone disease, menopausal status, hysterectomy, hormone replacement therapy (HRT), and current smoking. 223 participants self-reported OA while 4896 did not. Between 1997-2000, 3883 women (mean age 54.8±2.2) returned for a 2 nd visit and underwent similar investigations. At this visit 687 women self-reported OA. Results: Women with OA were significantly (p<0.001) heavier at baseline 68.73±0.53 kg and follow-up 71.80±0.55 kg visits than those without OA; baseline 65.40±0.23 kg, follow-up 68.00±0.24 kg. Preliminary results indicate that the risk of OA was significantly higher among women who had had a hysterectomy or who had stopped HRT. After adjustment for potential confounding factors such as age and weight, the odds ratios (95% confidence intervals) of OA among all hysterectomized women compared with controls was 1.34 (1.08, 1.66) (p=0.007). For women who had previously taken HRT but stopped, the odds ratio for reporting OA (95% CI) was 1.57 (1.28, 1.95), p=0.01. There was no increased risk in current HRT users, OR:1.13 (0.93, 1.39), p=0.22. Conclusions: In this population, a hysterectomy or ceasing HRT treatment was associated with an increase in self-reported OA. However, whether these factors are directly involved in the Purpose: Osteoarthritis (OA) is a leading cause of disability in the elderly. European recommendations (EULAR) for the treatment of knee OA (KOA) were updated in 2003. Optimal management requires a combination of non pharmacological treatment (NP) and pharmacological treatment, paracetamol (acetaminophen)(APAP) being the oral analgesic to try first and, if successful, the preferred long term oral analgesic. The aim of this study was to evaluate, in general practitioners (GPs), the first line therapeutic strategy evolution in patients (pts) with painful KOA over a 1-year (yr) period and whether it is in line with EULAR recommendations. Methods: This was an observational, prospective, multicenter 1-yr cohort study conducted in France (Fr) and Spain (Sp), with follow-up visits at months (M) 3, 6, 9 and 12. Pts were aged over 50 yr, suffering from painful KOA clinically defined (ACR criteria), not treated within the previous 6 months and for whom the GP planned to initiate a first line treatment based on EULAR recommendations. Results: 383 randomly selected GPs (Fr: 190/Sp: 193) included a total of 1075 pts (Fr 576/Sp 499). Baseline pts characteristics in Fr and Sp were similar: overall mean (SD) age 68 (10) yr, BMI 29 (5) kg/m 2 , OA duration 5 (6) yr, 743 (69%) females. Of the selected 1075 pts, 933 (87%) completed the 1-yr followup. Clinical characteristics at M0 (baseline) and M12 for all pts selected and for pts having completed the 1-yr follow-up are provided in table 1. Considering the 933 pts who completed the 1-yr follow-up: 925 (99%) had at least one APAP prescription over this period, 897 (96%) were prescribed APAP at M0, 766 (82%) at M12 and 665 (71%) continuously received APAP without interruption over the 1-yr period. 437 (47%) were prescribed a treatment strictly according the Eular recommendations at M0 (i.e. APAP as monotherapy associated with NP). Among them, 143 (33%) complied over the 1-yr period, 128 (29%) stopped NP, 84 (19%) required additional pharmacological treatment, 44 (5%) stopped APAP. Clinical signs globally improved over the 1-yr period: the % of pts with moderate to extreme pain decreased from 96% at M0 to 45% at M12 and the % of pts with signs of inflammation substantially decreased (Table 1) .
Conclusions:
This study provides major information on the long term management of pts with painful KOA in clinical practice. Nonpharmacological treatments remain insufficiently prescribed and, when initiated, are rarely continued over the long term.
On the other hand, first line pharmacological treatment with APAP was initiated for 96% pts and was well followed, 71% pts continuing APAP over the 1-yr period. Under these therapeutic conditions, after a 1-yr treatment period, improvement in pain, stiffness and clinical signs of inflammation was clinically relevant. The sonographic evaluation was conducted by a single sonography-expert rheumatologist and the patients were always assessed in the same position: supine decubitus with 30°flexion of the extremity. Joint effusion was considered to be present when sonography showed a hypoechogenic or an anechogenic collection displaceable and compressible by the probe pressure with an anteroposterior diameter bigger than 4 mm. The presence of joint effusion was measured by a semiquantitative scale: minimum, moderate and severe. In case of bilateral involvement, the most symptomatic knee was evaluated. Results: Results are shown in the table below: Conclusions: Among the 50 patients with symptomatic osteoarthritis studied, 15 presented joint effusion as measured by sonography. Severity of joint effusion correlated with higher levels of pain (VAS) and functional incapacity (Lequesne index), though not with more advanced radiological grades of osteoarthritis.
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USE OF SONOGRAPHY TO EVALUATE THE PRESENCE OF JOINT EFFUSION IN GONARTHROSIS AND ITS CORRELATION WITH PAIN, FUNCTIONAL CAPACITY AND DEGREE OF RADIOLOGICAL INVOLVEMENT
